Compare · CHPT vs STE
CHPT vs STE
Side-by-side comparison of ChargePoint Holdings Inc. (CHPT) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- CHPT operates in Consumer Discretionary, while STE operates in Health Care - the two are in different parts of the market.
- STE is the larger of the two at $21.26B, about 145.8x CHPT ($145.8M).
- Over the past year, CHPT is down 55.0% and STE is down 3.4% - STE leads by 51.6 points.
- CHPT has been more active in the news (10 items in the past 4 weeks vs 1 for STE).
- CHPT has more recent analyst coverage (25 ratings vs 16 for STE).
- Company
- ChargePoint Holdings Inc.
- STERIS plc (Ireland)
- Price
- $5.63-2.93%
- $217.88-1.46%
- Market cap
- $145.8M
- $21.26B
- 1M return
- -21.70%
- +5.46%
- 1Y return
- -55.00%
- -3.39%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 10
- 1
- Recent ratings
- 25
- 16
ChargePoint Holdings Inc.
ChargePoint Holdings, Inc. provides electric vehicle (EV) charging networks and charging solutions in the United States. It offers a portfolio of hardware, software, and services for commercial, fleet, and residential customers. The company was founded in 2007 and is headquartered in Campbell, California.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest CHPT
- ChargePoint and Onvo Expand Highway Fast Charging Across the Northeastern U.S.
- ChargePoint and Optimus Energy Solutions Partner to Build New Fast Charging Network in the Eastern U.S
- ChargePoint Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- ChargePoint Added to Membership of Russell 2000® Index
- CCXO Singh Jagdeep Ca sold $69,350 worth of shares (9,719 units at $7.14), decreasing direct ownership by 5% to 187,846 units (SEC Form 4) (tax liability)
- CRO Vice John David sold $29,053 worth of shares (4,072 units at $7.13), decreasing direct ownership by 2% to 171,507 units (SEC Form 4) (withholding obligation)
- CFO Khetani Mansi sold $58,165 worth of shares (8,152 units at $7.13), decreasing direct ownership by 4% to 179,348 units (SEC Form 4) to satisfy tax liability
- CAO Novruzova Natella Fakhradovna sold $15,996 worth of shares (2,242 units at $7.13), decreasing direct ownership by 7% to 29,315 units (SEC Form 4) (tax withholding)
- President and CEO Wilmer Richard covered exercise/tax liability with 7,631 shares, decreasing direct ownership by 1% to 503,593 units (SEC Form 4)
- General Counsel Batill Eric sold $35,523 worth of shares (4,979 units at $7.13), decreasing direct ownership by 3% to 143,631 units (SEC Form 4) to satisfy tax liability
Latest STE
- Director Sohi Mohsen exercised 3,781 units of Ordinary Shares at a strike of $71.40 and covered exercise/tax liability with 1,837 units of Ordinary Shares, increasing direct ownership by 9% to 24,305 units (SEC Form 4)
- SEC Form 11-K filed by STERIS plc (Ireland)
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam sold $296,968 worth of Ordinary Shares (1,419 units at $209.28), decreasing direct ownership by 4% to 35,259 units (SEC Form 4)
- SEC Form 144 filed by STERIS plc (Ireland)
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam covered exercise/tax liability with 401 units of Ordinary Shares, decreasing direct ownership by 1% to 36,678 units (SEC Form 4)
- V.P. & Corporate Treasurer Tamaro Renato covered exercise/tax liability with 65 units of Ordinary Shares, decreasing direct ownership by 1% to 6,194 units (SEC Form 4)
- Sr. VP and GM, Life Sciences Madsen Julia covered exercise/tax liability with 195 units of Ordinary Shares, decreasing direct ownership by 2% to 12,257 units (SEC Form 4)
- SVP & GM, AST Kohler Kenneth E covered exercise/tax liability with 150 units of Ordinary Shares, decreasing direct ownership by 1% to 11,332 units (SEC Form 4)
- SVP & Chief HRO Fraser Mary Clare covered exercise/tax liability with 600 units of Ordinary Shares, decreasing direct ownership by 4% to 13,716 units (SEC Form 4)
- President and CEO Carestio Daniel A covered exercise/tax liability with 1,889 units of Ordinary Shares and sold $946,799 worth of Ordinary Shares (4,428 units at $213.82), decreasing direct ownership by 9% to 63,647 units (SEC Form 4)